A Study in Asthma Patients to Evaluate Efficacy, Safety and Tolerability of 14 Days Once Daily Inhaled Interferon Beta-1a After the Onset of Symptoms of an Upper Respiratory Tract Infection

Condition: AsthmaInterventions: Drug: Interferon beta-1a Nebuliser solution 48 μg/mL; Drug: PlaceboSponsor: AstraZenecaNot yet recruiting - verified July 2015

http://clinicaltrials.gov/ct2/show/NCT02491684?lup_s=06%2F18%2F2015&lup_d=30

Source: ClinicalTrials.gov - June 16, 2015 Category: Research Source Type: clinical trials